Where is VantAI located?

VantAI is headquartered in New York City, United States.

How many employees does VantAI have?

As of Jul 01, 2024, the latest employee count at VantAI is 32.

Is VantAI a funded company?

VantAI is a funded company, having raised a total of $***** in its 1st and only funding round.

Where does VantAI rank among its competitors?

VantAI ranks 7th amongst 90 active competitors, of which 21 are funded. It stands 9th in terms of total funding among its competitors. The most recent competitor to raise funding was Tahoe Bio, which secured $30M in Aug, 2025.

Who are the top competitors of VantAI?

VantAI's top competitors include Algorithmic Biologics, Tahoe Bio and Metaphore. Among them, Tahoe Bio secured the most recent funding round in August, 2025.

VantAI - 2026 Company Profile & Competitors

Company Details

VantAI provides a platform for computational drug designing using AI. The company helps in de novo drug designing, prediction of drug target, in silico ADMET, and interactive mapping. It combines machine learning with analytical tools using AI to build computational models. The company's in silico platform helps in analyzing protein-protein interactions and lead to the discovery of small-molecule drugs.

Website: vant.ai
Email ID: *****@vant.ai

Key Metrics

Founded Year

2019

Location

New York City, United States

Stage

Unfunded

Ranked

7^th among 90 active competitors

Employee Count

32 as on Jul 01, 2024

Similar Companies

Innovaccer & 2407 more

View VantAI's full profile

VantAI has not raised any funding rounds yet.

VantAI's employee count trend

VantAI has 32 employees as of Jul 24. Here is VantAI's employee count trend over the years:

Uncover VantAI's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of VantAI include Algorithmic Biologics, Tahoe Bio and Metaphore. Here is the list of Top 10 competitors of VantAI, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Algorithmic Biologics 2021, Bengaluru (India), Seed	Provider of software solutions for molecular diagnostics and discovery	$2.84M	Bharat Innovation Fund, Axilor Ventures & 4 others	53/100
2nd	Tahoe Bio 2022, San Francisco (United States), Series B	Developer of AI models for drug design using single-cell maps.	$30M	Amplify Partners, Wing Venture Capital & 6 others	51/100
3rd	Metaphore 2021, Cambridge (United States), Series C	Provider of machine language and computational platform for drug discovery	$50M	Flagship Pioneering	51/100
4th	Panakeia 2018, London (United Kingdom), Seed	Provider of AI-based software for diagnosis and precision treatment	$3.79M	LocalGlobe, P4 & 4 others	50/100
5th	PharmaTher 2020, Toronto (Canada), Public	Provider of AI-based platform for repurposing psychedelic drugs	-	-	47/100
6th	Evolved By Nature 2013, Medford (United States), Series C	Digital molecule development technology for research	$211M	The Kraft Group, Ontario Teachers' Pension Plan ... & 6 others	45/100
7th	VantAI 2019, New York City (United States), Unfunded	Provider of a platform for computational drug designing using AI	-	-	45/100
8th	Wisecube 2016, Seattle (United States), Acquired	AI-based drug designing and development tool for researchers	-	-	44/100
9th	StoneWise 2018, Haidian (China), Series B	Provider of a software solution solution for molecular modeling	$100M	Hillhouse, Legend Capital & 7 others	43/100
10th	QuanMol Tech 2022, Canada, Seed	Provider of AI based solutions in molecular designing	$3M	Plug and Play Tech Center, Hat-Trick Capital ... & 3 others	40/100